A former California State treasurer with nearly two decades of experience as a senior bank executive, Kathleen Brown concentrates on business counseling, government, and regulatory affairs in connection with the health-care, energy, real estate, and financial services industries.

Alice Bonner has been a geriatric nurse practitioner caring for older adults and their families for over 30 years. She is currently adjunct faculty and director of strategic partnerships for the CAPABLE Program at the Johns Hopkins University School of Nursing and senior advisor for aging at the Institute for Healthcare Improvement.

Throughout her long career in science, Dr. Blackburn has been a leader in the area of telomere and telomerase research, having discovered the molecular nature of telomeres – the ends of eukaryotic chromosomes that serve as protective caps essential for preserving the genetic information – and co-discovered the ribonucleoprotein enzyme, telomerase. She is also known for her championing of diversity and inclusion in the sciences.

As the sixth managing partner in the 98-year history of Edward Jones, Penny Pennington is responsible for its strategic direction, working with more than 49,000 associates across North America to help 7 million clients achieve their financial goals. She was recently named to Barron’s inaugural 100 Most Influential Women in U.S. Finance and Fortune’s Most Powerful Women in Business lists.

Christopher Hite has advised hundreds of healthcare companies on projects ranging from mergers and acquisitions to capital formation. He has worked with some of the world’s leading companies, including Roche, GSK, Shire, Celgene, Astellas, and Johnson & Johnson.

As the head of Digital Health, Hon Pak, M.D leads the Global Digital Health Strategy and Team. His focus is to leverage Samsung’s digital footprint across multiple devices and its strength in consumer experience to transform this consumer experience into patient engagement to improve outcomes.

Dr. Margaret Hamburg, President of the American Association for the Advancement of Science (AAAS), is an internationally recognized leader in public health, medicine and science. Dr. Hamburg is a former Commissioner of the U.S. Food and Drug Administration, known for advancing regulatory science, modernizing regulatory pathways, and globalization of the agency.

Sarita A. Mohanty, MD, serves as the president and CEO of the SCAN Foundation.

Nancy Lynn is senior vice president, strategic partnerships at Bright Focus Foundation, a premier source of private research funding to understand, treat, and raise awareness about Alzheimer’s disease, macular degeneration, and glaucoma. Lynn also produces and raises distribution funding for disease-related documentary feature films.

Dr. Scott Gottlieb served as the 23rd Commissioner of the Food and Drug Administration (FDA) from May 2017 to April 2019. A medical policy expert and public health advocate, Dr. Gottlieb previously served as the FDA's Deputy Commissioner for Medical and Scientific Affairs and as a senior advisor to the FDA Commissioner.